Radical radiotherapy of prostate cancer requires a relatively high dose to achieve an optimal tumor control probability and a reduced dose to the critical structures related to the sexual function (S_OARs) in order to avoid erectile dysfunction. The aim of this study was to perform a planning feasibility analysis of a 3-level dose prescription with Simultaneous Integrated Boost (SIB) on the dominant intraprostatic lesion (DIL) and with S_OARs sparing.
Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study / Ciabatti S.; Ntreta M.; Buwenge M.; Gaudiano C.; Sessagesimi E.; Romani F.; Angelini A.L.; Cammelli S.; Macchia G.; Deodato F.; Zamagni A.; Golfieri R.; Morganti A.G.; Cilla S.. - In: MEDICAL DOSIMETRY. - ISSN 0958-3947. - ELETTRONICO. - 44:4(2019), pp. 356-364. [10.1016/j.meddos.2019.01.008]
Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study
Ciabatti S.;Buwenge M.;Sessagesimi E.;Cammelli S.;Zamagni A.;Golfieri R.;Morganti A. G.;
2019
Abstract
Radical radiotherapy of prostate cancer requires a relatively high dose to achieve an optimal tumor control probability and a reduced dose to the critical structures related to the sexual function (S_OARs) in order to avoid erectile dysfunction. The aim of this study was to perform a planning feasibility analysis of a 3-level dose prescription with Simultaneous Integrated Boost (SIB) on the dominant intraprostatic lesion (DIL) and with S_OARs sparing.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.